Disc Medicine Inc.
IRON | NASDAQ
$68.49
-$1.04 (-1.50%)
At close: Sep 21, 2026, 4:00 PM ET
$68.51
+$0.02 (+0.03%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Company Profile
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Key Executives
| Name | Position |
|---|---|
| John D. Quisel | Chief Executive Officer, President & Director |
| Jean Franchi | Chief Financial Officer |
| Rahul Khara | Chief Legal Officer & Secretary |
| Brian MacDonald | Founder & Chair of Scientific Advisory Board |
| Donald William Nicholson | Executive Chairman |
| Jonathan Yu | Chief Opearating Officer |
| Lisa Amaya Price | Chief Human Resources Officer |
| Pamela Stephenson | Chief Commercial Officer |
| Rahul Rajan Kaushik | Chief Technical Officer |
| William Jacob Savage | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 4 | Filing |
| Aug 26, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 14, 2026 | 4 | Filing |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Aug 07, 2026 | 4 | Filing |
| Aug 06, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 30, 2026 | 10-Q | Quarterly Report |
| Jul 30, 2026 | 8-K | Current Report |
| Jul 21, 2026 | 8-K | Current Report |
Disc Medicine Inc.
| Country | United States |
| IPO Date | Aug 11, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 165 |
| CEO | John D. Quisel |
Contact Details
321 Arsenal Street Watertown,
Massachusetts 02472 United States
Stock Details
| Ticker Symbol | IRON |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816736 |
| CUSIP Number | 254604101 |
| ISIN Number | US2546041011 |
| SIC Code | 2834 |
Recent News
- 13 hours ago / prnewswire.comRosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
- 1 day ago / defenseworld.netDisc Medicine, Inc. (NASDAQ:IRON) Receives Average Recommendation of “Moderate Buy” from Analysts
- 5 days ago / prnewswire.comRosen Law Firm Encourages Disc Medicine, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - IRON
- 6 days ago / globenewswire.comDisc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
- 8 days ago / seekingalpha.comDisc Medicine, Inc. (IRON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 13 days ago / newsfilecorp.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
- 14 days ago / prnewswire.comIRON, the World's First Advanced General-Purpose Humanoid Robot, Walks off the Production Lines as XPENG's Humanoid Robot Manufacturing Facility Is Officially Commissioned
- 20 days ago / globenewswire.comDisc Medicine to Participate in Upcoming Investor Conferences
- 26 days ago / defenseworld.netDisc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of “Moderate Buy” by Brokerages
- 28 days ago / newsfilecorp.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Add to Watchlist
Select watchlists to add or remove IRON